Deep Genomics
Deep Genomics's Overview
Deep Genomics is a pioneering biotechnology company at the forefront of using artificial intelligence (AI) and machine learning to transform drug discovery and development. Founded in 2015, the company focuses on identifying novel therapeutic targets and designing RNA-based medicines for genetic diseases. Their proprietary AI platform, the 'AI Workbench,' analyzes vast amounts of biological data to predict the effects of genetic mutations and identify molecules that can correct them, aiming to create a new generation of programmable medicines. Deep Genomics is dedicated to tackling previously untreatable conditions by unlocking the potential of RNA biology through computational innovation.
Where is Deep Genomics's Headquarters?
HQ Function
The Toronto headquarters serves as the central hub for Deep Genomics's research and development, AI platform development, corporate strategy, and administrative operations. It's where their core scientific and computational teams collaborate to advance their RNA therapy pipeline.
Notable Features:
Located within the MaRS Discovery District, one of the world's largest urban innovation hubs. This provides access to a vibrant ecosystem of startups, research institutions, and venture capital. The facilities are state-of-the-art, designed to support both computational and wet lab research.
Work Culture:
Deep Genomics fosters a highly collaborative, innovative, and mission-driven work culture. Employees are passionate about leveraging cutting-edge AI to solve complex biological problems and make a tangible impact on patients' lives. The environment encourages interdisciplinary teamwork between computational biologists, machine learning experts, and drug developers.
HQ Significance:
The MaRS Centre location is significant as it places Deep Genomics at the heart of Canada's leading scientific and tech community, facilitating collaborations, talent acquisition, and access to resources. It underscores their commitment to being at the forefront of AI in healthcare.
Values Reflected in HQ: The headquarters' location and design reflect values such as innovation, collaboration, scientific excellence, and a commitment to leveraging advanced technology for societal benefit.
Location:
While Deep Genomics's physical headquarters and primary operations are based in Toronto, Canada, its impact and collaborations are global. The company engages with the international scientific community, participates in global conferences, and aims to develop therapies for genetic diseases affecting populations worldwide. Their research and potential partnerships can span across different countries, supporting a global mission in advancing genomic medicine.
Street Address:
MaRS Centre, West Tower, 661 University Avenue, Suite 1200
City:
Toronto
State/Province:
Ontario
Country:
Canada
Deep Genomics's Global Presence
Primarily Centralized (Toronto, ON, Canada)
Address: Operations mainly consolidated at headquarters in MaRS Centre.
Focus on consolidating talent and resources within the Toronto biotech and AI innovation hub to foster deep collaboration and accelerate research.
Buying Intent Signals for Deep Genomics
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
Executive Team of Deep Genomics
As of April 2025, Deep Genomics' leadership includes:
Investors of Deep Genomics
Deep Genomics has been backed by several prominent investors over the years, including:
Executive New Hires/Exits in the Last 12 Months
Deep Genomics significantly reshaped its executive team over the last 12 months with key C-suite appointments, including a new Chief Operating Officer, Chief Scientific Officer, and Chief Financial Officer. Additionally, Megan Mahoney was promoted to President & CEO, with Founder Brendan Frey transitioning to Chief Innovation Officer.
New Appointments:
Technology (Tech Stack) used by Deep Genomics
Discover the tools Deep Genomics uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Deep Genomics Email Formats and Examples
Deep Genomics likely utilizes common professional email formats for its employees. While multiple patterns might be in use, observed formats include [first].[last]@deepgenomics.com and [first]@deepgenomics.com. Using a standard professional format increases the likelihood of successful communication.
[first].[last]@deepgenomics.com
Format
jane.doe@deepgenomics.com
Example
75%
Success rate
News and media
Business Wire • May 15, 2024
Deep Genomics Presents Preclinical Data at TIDES USA 2024 Demonstrating AI-Platform Designed siRNAs Show Potent and Durable Gene Silencing
Deep Genomics shared new preclinical data at the TIDES USA 2024 conference, highlighting the capabilities of its AI drug discovery platform in designing potent and durable short interfering RNAs (siRNAs) for gene silencing. The data supports the platform's ability to optimize therapeutic candidates for genetic diseases....more
Deep Genomics Press Release • October 4, 2023
Deep Genomics Appoints Sophia Kalamchi as Chief Operating Officer
Deep Genomics announced the appointment of Sophia Kalamchi, M.Sc., PMP, as Chief Operating Officer. Ms. Kalamchi brings extensive experience in R&D operations, strategy, and program management to scale Deep Genomics' operations as it advances its AI-discovered genetic medicines....more
Deep Genomics Press Release • July 12, 2023
Deep Genomics Appoints Megan Mahoney as President and Chief Executive Officer
Deep Genomics announced that its Board of Directors has appointed Megan Mahoney as President and Chief Executive Officer. Brendan Frey, Founder, transitioned to the role of Chief Innovation Officer and remains on the Board. Mahoney previously served as President and Chief Business Officer....more
Highperformr’s free tools for company research
Explore Employees by Region or Country
See where a company’s workforce is located, by country or region.
View Funding Details
View past and recent funding rounds with amounts and investors.
Understand Revenue Insights
Understand company revenue estimates and financial scale.
Track Active Job Openings
Track active roles and hiring trends to spot growth signals.
Review Product and Offerings
Discover what a company offers—products, platforms, and solutions.
Get SIC or NAICS Codes
Get the company’s official SIC and NAICS classifications.
Analyze Website Traffic Trends
Analyze visitor volume, engagement, and top traffic sources.
Discover Social Profiles and Engagement
Explore LinkedIn, Twitter, and other active social profiles.
Identify Top Competitors
Identify top competitors based on similar business traits.
Research and Discover Companies with Highperformr — Smarter, Faster
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
- Track intent signals to find buyers who are actively in-market
- Enrich contacts and companies instantly, no need to switch tools
- Automate workflows to stay ahead of every change
- Connect your CRM & tools for seamless data sync and activation
Thousands of companies, including Deep Genomics, are just a search away.